Showing results (351-360 of 536) with videos related to
Sort By:
Pageof 54
Annals of Translational Medicine|May 14, 2021
Marriage contributes to higher obesity risk in China: findings from the China Health and Nutrition SurveyJinli Liu, Malgorzata A Garstka, Zhonglin Chai, et al.Journal of the American Society of Nephrology : JASN|July 17, 2010
Comparison of different measures of urinary protein excretion for prediction of renal eventsHiddo J Lambers Heerspink, Ron T Gansevoort, Barry M Brenner, et al.American Journal of Physiology. Renal Physiology|June 18, 2010
The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouseSara Giunti, Anna C Calkin, Josephine M Forbes, et al.Kidney International|October 4, 2013
Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7bBo Wang, Jay C Jha, Shinji Hagiwara, et al.Atherosclerosis|June 20, 2014
Quinapril treatment abolishes diabetes-associated atherosclerosis in RAGE/apolipoprotein E double knockout miceAnna M D Watson, Jiaze Li, Dian Samijono, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 11, 2003
Does vascular endothelial growth factor (VEGF) play a role in the pathogenesis of minimal change disease?Geoffrey Boner, Alison J Cox, Darren J Kelly, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2005
Rosiglitazone attenuates atherosclerosis in a model of insulin insufficiency independent of its metabolic effectsAnna C Calkin, Josephine M Forbes, Craig M Smith, et al.Nephron. Physiology|January 31, 2004
A study of VEGF and its receptors in two rat models of proteinuriaJohn Kanellis, Vicki Levidiotis, Tiffany Khong, et al.Diabetologia|June 22, 2019
Endothelial or vascular smooth muscle cell-specific expression of human NOX5 exacerbates renal inflammation, fibrosis and albuminuria in the Akita mouseJay C Jha, Aozhi Dai, Chet E Holterman, et al.Journal of Hypertension|March 6, 2012
An initial reduction in serum uric acid during angiotensin receptor blocker treatment is associated with cardiovascular protection: a post-hoc analysis of the RENAAL and IDNT trialsPaul A Smink, Stephan J L Bakker, Gozewijn D Laverman, et al.Pageof 54